Doug Bayliss, PhD, Earns $2.8 Million NIH Grant to Study the CO₂ Sensing Mechanisms That Control Breathing

Doug Bayliss, PhD, Earns $2.8 Million NIH Grant to Study the CO₂ Sensing Mechanisms That Control Breathing

Doug Bayliss, PhD, Earns $2.8 Million NIH Grant to Study the CO₂ Sensing Mechanisms That Control Breathing

Doug Bayliss, PhD, Earns $2.8 Million NIH Grant to Study the CO₂ Sensing Mechanisms That Control Breathing
Q&A: Is the medical community on the brink of a cure for Huntington’s disease?

Q&A: Is the medical community on the brink of a cure for Huntington’s disease?

The director of UVA’s treatment program sees reason for “cautious optimism” after a small study’s positive results.

UVA Today

Q&A: Is the medical community on the brink of a cure for Huntington’s disease?
Sarah Ewald, PhD, Earns Five-Year $2.3 million NIH-R35 Award to Study Innate Inflammatory Control of Cachexia

Sarah Ewald, PhD, Earns Five-Year $2.3 million NIH-R35 Award to Study Innate Inflammatory Control of Cachexia

Sarah Ewald, PhD, Earns Five-Year $2.3 million NIH-R35 Award to Study Innate Inflammatory Control of Cachexia

Sarah Ewald, PhD, Earns Five-Year $2.3 million NIH-R35 Award to Study Innate Inflammatory Control of Cachexia

UVA-Born Technology Goes From Lab Bench to Bedside With Global Impact

How Ailing Immune Cells May Drive Alzheimer's

How Ailing Immune Cells May Drive Alzheimer’s

How Ailing Immune Cells May Drive Alzheimer's

How Ailing Immune Cells May Drive Alzheimer's